Wall Street Journal - Lack of Vitamin B1 May Lead to Alzheimer’s


Our grantee Dr. Gary Gibson discusses the link between a lack of Vitamin B1 and Alzheimer’s disease in an interview with The Wall Street Journal. Dr. Gibson is embarking on a Phase 2 clinical trial of benofotiamine (which raises B1 levels), funded by a partnership between the Alzheimer’s Drug Discovery Foundation, Burke Rehabilitation Hospital, and the National Institutes of Health (NIH).